Inflammatory Disease: Leading the Fight In Treatment
Wednesday September 18, 2019
Inflammation is a primary driver behind many fatal and life-threatening diseases. By targeting inflammation, Abcentra hopes to alleviate symptoms and treat underlying disease, creating a fuller life for patients.
Abcentra is developing a novel solution to treat critical diseases for which no current treatment options exist, saving patient lives.